Moderna
MRNA
#1078
Rank
โ‚ฌ18.44 B
Marketcap
46,70ย โ‚ฌ
Share price
1.16%
Change (1 day)
46.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -โ‚ฌ2.88 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚ฌ2.20 Billion. In 2024 the company made an earning of -โ‚ฌ3.11 Billion, an increase over its 2023 earnings that were of -โ‚ฌ3.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ2.88 Billion-7.36%
2024 -โ‚ฌ3.11 Billion-8.22%
2023 -โ‚ฌ3.39 Billion-140.65%
2022 โ‚ฌ8.31 B-27.81%
2021 โ‚ฌ11.52 B-1911.15%
2020 -โ‚ฌ0.64 Billion44.7%
2019 -โ‚ฌ0.44 Billion28.63%
2018 -โ‚ฌ0.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.05 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.16 B-619.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚ฌ19.99 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚ฌ41.08 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ36.17 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.11 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ0.12 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA